Page last updated: 2024-08-23

idarubicin and leupeptins

idarubicin has been researched along with leupeptins in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Grimes, BA; Guzman, ML; Howard, DS; Jordan, CT; Rossi, RM; Swiderski, CF; Szilvassy, SJ	1
Belloc, F; de Verneuil, H; Lacombe, F; Mahon, FX; Milpied, N; Moreau-Gaudry, F; Pigneux, A; Praloran, V; Reiffers, J; Uhalde, M	1
Lu, SX	1

Reviews

1 review(s) available for idarubicin and leupeptins

Article	Year
[Tumor stem cells and their impact on the concept of cancer treatment]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2010, Volume: 32, Issue:2 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Humans; Idarubicin; Leupeptins; Neoplasms; Neoplastic Stem Cells	2010

Other Studies

2 other study(ies) available for idarubicin and leupeptins

Article	Year
Preferential induction of apoptosis for primary human leukemic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 2002, Dec-10, Volume: 99, Issue:25 Topics: Acute Disease; Alleles; Animals; Antibiotics, Antineoplastic; Apoptosis; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Gene Expression Regulation, Leukemic; Graft Survival; Hematopoietic Stem Cells; Humans; I-kappa B Proteins; Idarubicin; Leukemia, Myeloid; Leukocytes; Leupeptins; Mice; Mice, Inbred NOD; Mice, SCID; Multienzyme Complexes; Neoplasm Proteins; Neoplasm Transplantation; Neoplastic Stem Cells; NF-kappa B; Proteasome Endopeptidase Complex; Recombinant Fusion Proteins; Tumor Suppressor Protein p53	2002
Proteasome inhibition specifically sensitizes leukemic cells to anthracyclin-induced apoptosis through the accumulation of Bim and Bax pro-apoptotic proteins. Cancer biology & therapy, 2007, Volume: 6, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Bcl-2-Like Protein 11; Boronic Acids; Bortezomib; Cell Line, Tumor; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Leupeptins; Male; Membrane Proteins; Middle Aged; Protease Inhibitors; Proteasome Inhibitors; Proto-Oncogene Proteins; Pyrazines; Tumor Cells, Cultured	2007

Article

Year

Preferential induction of apoptosis for primary human leukemic stem cells.

Proceedings of the National Academy of Sciences of the United States of America, 2002, Dec-10, Volume: 99, Issue:25

Topics: Acute Disease; Alleles; Animals; Antibiotics, Antineoplastic; Apoptosis; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Gene Expression Regulation, Leukemic; Graft Survival; Hematopoietic Stem Cells; Humans; I-kappa B Proteins; Idarubicin; Leukemia, Myeloid; Leukocytes; Leupeptins; Mice; Mice, Inbred NOD; Mice, SCID; Multienzyme Complexes; Neoplasm Proteins; Neoplasm Transplantation; Neoplastic Stem Cells; NF-kappa B; Proteasome Endopeptidase Complex; Recombinant Fusion Proteins; Tumor Suppressor Protein p53

2002

Proteasome inhibition specifically sensitizes leukemic cells to anthracyclin-induced apoptosis through the accumulation of Bim and Bax pro-apoptotic proteins.

Cancer biology & therapy, 2007, Volume: 6, Issue:4

Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Bcl-2-Like Protein 11; Boronic Acids; Bortezomib; Cell Line, Tumor; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Leupeptins; Male; Membrane Proteins; Middle Aged; Protease Inhibitors; Proteasome Inhibitors; Proto-Oncogene Proteins; Pyrazines; Tumor Cells, Cultured

2007